| # | Title | Journal | Year | Citations |
|---|
| 1 | Inflammatory responses and inflammation-associated diseases in organs | Oncotarget | 2018 | 2,597 |
| 2 | Combination therapy in combating cancer | Oncotarget | 2017 | 1,471 |
| 3 | Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients | Oncotarget | 2016 | 821 |
| 4 | Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway | Oncotarget | 2015 | 626 |
| 5 | The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer | Oncotarget | 2015 | 533 |
| 6 | Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas | Oncotarget | 2012 | 532 |
| 7 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health | Oncotarget | 2011 | 509 |
| 8 | The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis | Oncotarget | 2016 | 500 |
| 9 | Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer | Oncotarget | 2016 | 485 |
| 10 | Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer | Oncotarget | 2014 | 467 |
| 11 | The regulation of β-catenin activity and function in cancer: therapeutic opportunities | Oncotarget | 2017 | 465 |
| 12 | The molecular mechanisms of chemoresistance in cancers | Oncotarget | 2017 | 459 |
| 13 | Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease | Oncotarget | 2015 | 449 |
| 14 | Aldehyde dehydrogenase 1A1 in stem cells and cancer | Oncotarget | 2016 | 448 |
| 15 | An emerging function of circRNA-miRNAs-mRNA axis in human diseases | Oncotarget | 2017 | 429 |
| 16 | Prognostic and predictive value of PDL1 expression in breast cancer | Oncotarget | 2015 | 424 |
| 17 | Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death | Oncotarget | 2015 | 422 |
| 18 | On the presence and role of human gene-body DNA methylation | Oncotarget | 2012 | 409 |
| 19 | EMT, CTCs and CSCs in tumor relapse and drug-resistance | Oncotarget | 2015 | 408 |
| 20 | GSK-3 as potential target for therapeutic intervention in cancer | Oncotarget | 2014 | 407 |
| 21 | The role of p53 in cancer drug resistance and targeted chemotherapy | Oncotarget | 2017 | 407 |
| 22 | Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer | Oncotarget | 2016 | 403 |
| 23 | Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease | Oncotarget | 2015 | 401 |
| 24 | PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma | Oncotarget | 2016 | 400 |
| 25 | Classification of current anticancer immunotherapies | Oncotarget | 2014 | 395 |
| 26 | Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation | Oncotarget | 2015 | 395 |
| 27 | Cold atmospheric plasma, a novel promising anti-cancer treatment modality | Oncotarget | 2017 | 393 |
| 28 | Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? | Oncotarget | 2017 | 389 |
| 29 | Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers | Oncotarget | 2011 | 383 |
| 30 | Mitochondrial dysfunction and oxidative stress in aging and cancer | Oncotarget | 2016 | 381 |
| 31 | Porphyrin photosensitizers in photodynamic therapy and its applications | Oncotarget | 2017 | 381 |
| 32 | Targeting the CCL2-CCR2 signaling axis in cancer metastasis | Oncotarget | 2016 | 378 |
| 33 | Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival | Oncotarget | 2010 | 371 |
| 34 | Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers | Oncotarget | 2014 | 367 |
| 35 | Stability of the hybrid epithelial/mesenchymal phenotype | Oncotarget | 2016 | 367 |
| 36 | Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics | Oncotarget | 2012 | 365 |
| 37 | Hallmarks of glycosylation in cancer | Oncotarget | 2016 | 358 |
| 38 | iACP: a sequence-based tool for identifying anticancer peptides | Oncotarget | 2016 | 354 |
| 39 | TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype | Oncotarget | 2016 | 353 |
| 40 | Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a | Oncotarget | 2014 | 338 |
| 41 | Alterations of immune response of non-small cell lung cancer with Azacytidine | Oncotarget | 2013 | 336 |
| 42 | Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing | Oncotarget | 2014 | 331 |
| 43 | OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research | Oncotarget | 2016 | 330 |
| 44 | Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway | Oncotarget | 2015 | 329 |
| 45 | EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy | Oncotarget | 2014 | 324 |
| 46 | A versatile system for rapid multiplex genome-edited CAR T cell generation | Oncotarget | 2017 | 319 |
| 47 | Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare | Oncotarget | 2018 | 315 |
| 48 | Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence | Oncotarget | 2016 | 309 |
| 49 | Targeting folate receptor alpha for cancer treatment | Oncotarget | 2016 | 308 |
| 50 | Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy | Oncotarget | 2016 | 306 |
